Gabriella Miller Kids First Research Act 2.0
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Apr 17, 2020)
Gabriella Miller Kids First Research Act 2.0
This bill directs certain penalties assessed by the Securities Exchange Commission against pharmaceutical companies for specified violations to the 10-Year Pediatric Research Initiative Fund, an existing fund that supports pediatric disease research. In making allocations from that fund, the National Institutes of Health shall prioritize pediatric research that does not duplicate existing research activities.
What just happenedApr 17, 2020
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Who’s behind it
- Introduced in HouseApr 17, 2020
- Apr 17, 2020IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Financial Services Committee - Apr 17, 2020IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Apr 17, 2020IntroReferralB00100
Sponsor introductory remarks on measure. (CR E373)
- Apr 17, 2020IntroReferralIntro-H
Introduced in House
- Apr 17, 2020IntroReferral1000
Introduced in House